Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Michael Burry Turns Bullish on Fannie & Freddie as IPO Nears, but Warns of Key Regulatory Hurdles

by Team Lumida
1 day ago
Michael Burry Turns Bullish on Fannie & Freddie as IPO Nears, but Warns of Key Regulatory Hurdles

Key Takeaways Powered by lumidawealth.com Michael Burry disclosed large personal positions in Fannie Mae and Freddie Mac common stock. He believes a relisting/IPO is “nearly upon us,” but only...

Read more

Paramount Launches $77.9B Hostile Bid for Warner, Escalating Battle With Netflix

by Team Lumida
1 day ago
flat screen television displaying Netflix logo

Key Takeaways Powered by lumidawealth.com Paramount unveiled a $77.9B all-cash hostile takeover offer for Warner, topping Netflix’s recently announced $72B bid. The offer goes directly to shareholders, bypassing Warner’s...

Read more

PepsiCo Strikes Deal With Elliott, Pledges Cost Cuts and Lower Food Prices

by Team Lumida
1 day ago
pepsi can on gray table

Key Takeaways Powered by lumidawealth.com PepsiCo agreed to cut costs and lower food prices following pressure from activist investor Elliott Investment Management. The company will reduce its U.S. product...

Read more

Trump Raises Antitrust Concerns Over Netflix’s $72 Billion Acquisition of Warner Bros.

by Team Lumida
2 days ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways:Powered by lumidawealth.com President Trump expressed potential antitrust concerns regarding Netflix’s $72 billion acquisition of Warner Bros., citing the combined market share of the two entities. The deal...

Read more

Solar Installations Rush to Beat Tax Credit Deadline Faces Delays Amid Permitting Backlog

by Team Lumida
2 days ago
Solar Installations Rush to Beat Tax Credit Deadline Faces Delays Amid Permitting Backlog

Key Takeaways:Powered by lumidawealth.com The rush to install solar and battery systems by December 31 to qualify for the 30% tax credit is driving a surge in demand for...

Read more

Netflix Acquires Warner Bros. for $72 Billion, Expanding Content Library and Movie Theatrical Presence

by Team Lumida
2 days ago
flat screen television displaying Netflix logo

Key Takeaways: Powered by lumidawealth.com Netflix is acquiring Warner Bros. for $72 billion, adding iconic film franchises and TV shows to its portfolio. The deal will give Netflix a...

Read more

Netflix’s $72B Warner Bros. Deal Faces Heavy Scrutiny From Trump Administration and Regulators

by Team Lumida
4 days ago
person holding remote pointing at TV

Key Takeaways Powered by lumidawealth.com Netflix secured a $72 billion agreement to acquire Warner Bros. studios and HBO Max but must now pass Justice Department review. Trump administration officials...

Read more

Who Wins and Loses if Fannie Mae and Freddie Mac Go Public Again?

by Team Lumida
5 days ago
Who Wins and Loses if Fannie Mae and Freddie Mac Go Public Again?

Key Takeaways Powered by lumidawealth.com The Trump administration is preparing a potential stock offering for Fannie Mae and Freddie Mac to reduce government ownership. Deal structure will determine outcomes...

Read more

Apple Faces Leadership Drain as Rivals Poach Talent and Push AI Hardware Ambitions

by Team Lumida
5 days ago
Apple Faces Leadership Drain as Rivals Poach Talent and Push AI Hardware Ambitions

Key Takeaways Powered by lumidawealth.com Apple has seen multiple senior departures—including its general counsel, head of policy, head of AI strategy, COO, CFO, and key designers—in less than a...

Read more

Netflix Enters Exclusive Talks to Buy Warner Bros., Signaling a Historic Shake-Up in Hollywood

by Team Lumida
5 days ago
Netflix Enters Exclusive Talks to Buy Warner Bros., Signaling a Historic Shake-Up in Hollywood

Key Takeaways Powered by lumidawealth.com Warner Bros. Discovery is in exclusive negotiations to sell its film/TV studios and HBO Max to Netflix. Netflix has offered a $5 billion breakup...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

selective focus photo of Bitcoin near monitor

Bitcoin Rises Ahead of Fed Decision as Investors Eye Potential Policy Shift

March 19, 2025
text

Surprise Yen Intervention: Japan’s $22 Billion Strategy

July 12, 2024
two space gray and two silver iPhone 11's

Apple’s 2024 Strategy: More iPhones, Advanced AI, and New Market Tactics

July 11, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018